Inhibition of human pancreatic and biliary output but not intestinal motility by physiological intraileal lipid loads

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 4, 2006, Pages

  Keller, Jutta ^a   Holst, Jens Juul ^b   Layer, Peter ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biliary function; Intestinal nutrients; Pancreatic exocrine function

Indexed keywords

BILE ACID; ESSENTIAL AMINO ACID; GLUCAGON LIKE PEPTIDE; LIPID; PANCREAS ENZYME; PEPTIDE YY; PROTEINASE; TRYPSIN;

ADULT; ARTICLE; BILE SECRETION; BLOOD SAMPLING; COLON; CONTROLLED STUDY; CORRELATION ANALYSIS; DUODENUM; EXPOSURE; FEMALE; HUMAN; HUMAN EXPERIMENT; ILEUM; INTESTINE MOTILITY; INTESTINE PERFUSION; INTUBATION; MALE; MANOMETRY; MEDIATOR; MOTOR ACTIVITY; NORMAL HUMAN; NUTRIENT; PANCREAS SECRETION; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; STIMULATION; STOMACH SUCTION; TUBE; VENOUS BLOOD;

ADULT; BILE; ENTERAL NUTRITION; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; ILEUM; LIPID METABOLISM; LIPIDS; MALE; PANCREAS; PERFUSION; TRYPSIN;

EID: 33645836320     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00411.2005     Document Type: Article

References (39)

1. Adler G, Beglinger C, Braun U, Reinshagen M, Koop I, Schafmayer A, Rovati L, and Arnold R. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. Gastroenterology 100: 537-543, 1991.
2. Arndorfer RC, Stef JJ, Dodds WJ, Linehan JH, and Hogan WJ. Improved infusion system for intraluminal esophageal manometry. Gastroenterology 73: 23-27, 1977.
3. Beglinger C, Hildebrand P, Adler G, Werth B, Luo H, Delco F, and Gyr K. Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man. Eur J Clin Invest 22: 827-834, 1992.
4. Borgstrom B, Dahlqvist A, Lundh G, and Sjovall J. Studies of intestinal digestion and absorption in the human. J Clin Invest 36: 1521-1536, 1957.
5. Box GEP, Hunter WG, and Hunter JS. Statistics for Experimenters: An Introduction to Design, Data Analysis, and Model Building. New York: Wiley, 1978.
6. Brunner H, Northfield TC, Hofmann AF, Go VLW, and Summerskill WH. Gastric emptying and secretion of bile acids, cholesterol, and pancreatic enzymes during digestion: duodenal perfusion studies in healthy subjects. Mayo Clin Proc 49: 851-860, 1974.
7. Chey WY and Chang T. Neural hormonal regulation of exocrine pancreatic secretion. Pancreatology 1: 320-335, 2001.
8. Clain JE, Go VLW, and Malagelada JR. Inhibitory role of the distal small intestine on the gastric secretory response to meals in man. Gastroenterology 74: 704-707, 1978.
9. Dobson CL, Davis SS, Chauhan S, Sparrow RA, and Wilding IR. Does the site of intestinal delivery of oleic acid alter the ileal brake response? Int J Pharm 195: 63-70, 2000.
10. Fields M and Duthie HL. Effect of vagotomy on intraluminal digestion of fat in man. Gut 6: 301-310, 1965.
11. Franke A, Keller J, Groeger G, Rosien U, Holst JJ, and Layer P. Glucagon-like peptide-1 strongly affects duodeno-cecal transit time, but only weakly small intestinal motility index in humans (Abstract). Gastroenterology 118, Suppl 2: 3243, 2000.
12. Franke A, Keller J, Holst JJ, Goebell H, and Layer P. Glucagon-like peptide-1 decreases human endogenously stimulated exocrine pancreatic secretion (Abstract). Pancreas 13: 436, 1996.
13. Go VLW, Hofmann AF, and Summerskill WH. Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique. Gastroenterology 58: 321-328, 1970.
14. Hammer HF, Santa Ana CA, Schiller LR, and Fordtran JS. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest 84: 1056-1062, 1989.
15. Hofmann AF and Borgstroem B. The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J Clin Invest 43: 247-257, 1964.
16. Hummel B. A modified spectrophotometric determination of trypsin, chymotrypsin, and thrombin. Can J Biochem 37: 1393-1397, 1955.
17. Keller J, Franke A, Rippel K, Holst JJ, Goebell H, and Layer P. Termination of digestive pancreatic secretory and intestinal motor responses: importance of GLP-1 and PYY (Abstract). Digestion 60: 383, 1999.
18. Keller J and Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut 54, Suppl 6: vi1-vi28, 2005.
19. Keller J, Runzi M, Goebell H, and Layer P. Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic responses to a meal. Am J Physiol Gastrointest Liver Physiol 272: G632-G637, 1997.
20. Kinsman RI and Read NW. Effect of naloxone on feedback regulation of small bowel transit by fat. Gastroenterology 87: 335-337, 1984.
21. Koop I, Dorn S, Koop H, Witzleb S, Beglinger C, Schafmayer A, and Arnold R. Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans. Dig Dis Sci 36: 1625-1632, 1991.
22. Layer P, Groger G, Ohe M, and Goebell H. Ileal carbohydrates alter intestinal fed motor pattern in response to weak but not to strong endogenous stimulation (Abstract). Gastroenterology 100: 462, 1991.
23. Layer P, Holst JJ, Grandt D, and Goebell H. Ileal release of glucagon-like peptide-1 (GLP-1): association with inhibition of gastric acid secretion in humans. Dig Dis Sci 40: 1074-1082, 1995.
24. Layer P, Peschel S, Schlesinger T, and Goebell H. Human pancreatic secretion and intestinal motility: effects of ileal nutrient perfusion. Am J Physiol Gastrointest Liver Physiol 258: G196-G201, 1990.
25. Lin HC, Zhao XT, Wang L, and Wong H. Fat-induced ileal brake in the dog depends on peptide YY. Gastroenterology 110: 1491-1495, 1996.
26. Mashige F, Tanaka N, Maki A, Kamei S, and Yamanaka M. Direct spectrophotometry of total bile acids in serum. Clin Chem 27: 1352-1356, 1981.
27. Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Ørskov C, Ritzel R, and Schmiegel WH. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol Endocrinol Metab 273: E981-E988, 1997.
28. Ørskov C, Rabenhoj L, Wettergren A, Kofod H, and Holst JJ. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43: 535-539, 1994.
29. Pappas TN, Debas HT, and Taylor IL. Peptide YY: metabolism and effect on pancreatic secretion in dogs. Gastroenterology 89: 1387-1392, 1985.
30. Pironi L, Stanghellini V, Miglioli M, Corinaldesi R, De Giorgio R, Ruggeri E, Tosetti C, Poggioli G, Morselli-Labate AM, Monetti N, Gozzetti G, Barbara L, and Go VLW. Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology 105: 733-739, 1993.
31. Read NW, McFarlane A, Kinsman RI, Bates TE, Blackhall NW, Farrar GB, Hall JC, Moss G, Morris AP, and O'Neill B. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 86: 274-280, 1984.
32. Saslow SB, Camilleri M, Thomforde GM, Van Dyke CT, Pitot HC, and Rubin J. Relation between fat malabsorption and transit abnormalities in human carcinoid diarrhea. Gastroenterology 110: 405-410, 1996.
33. Schmidt PT, Ljung T, Hartmann B, Hare KJ, Holst JJ, and Hellström PM. Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY. Eur J Gastroenterol Hepatol 17: 207-212, 2005.
34. Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ, and Silk DB. The ileal brake: inhibition of jejunal motility after ileal fat perfusion in man. Gut 25: 365-374, 1984.
35. Tohno H, Sarr MG, and DiMagno EP. Intraileal carbohydrate regulates canine postprandial pancreaticobiliary secretion and upper gut motility. Gastroenterology 109: 1977-1985, 1995.
36. Vilsbøll T, Agersø H, Krarup T, and Holst JJ. Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects. J Clin Endocrinol Metab 88: 220-224, 2003.
37. Wahlefeld A. Triglyceride: Bestimmung nach enzymatischer Verseifung. In: Methoden der enzymatischen Analyse, edited by Bergmeier HU. Weinheim, Germany: Verlag Chemie, 1974, p. 1878-1882.
38. Wettergren A, Petersen H, Ørskov C, Christiansen J, Sheikh SP, and Holst JJ. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand J Gastroenterol 29: 501-505, 1994.
39. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, and Holst JJ. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38: 665-673, 1993.